SCHEMBL4417265

SCHEMBL4417265

Cc1nccn1CCC(=O)N1CCN(c2ccc(Cl)cc2)CC1(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ HTR7 P34969 3/20 0.42
▸ HTR1A P08908 3/20 0.42
▸ MAPT P10636 3/20 0.39
▸ F10 P00742 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ ADAMTS5 Q9UNA0 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MC4R P32245 1/20 0.36
▸ NR1H2 P55055 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4417932 0.91 ESR1 (0.47) MEN1KMT2ALMNARAB9AHTR7
SCHEMBL4428542 0.84 ALDH1A1 (0.38) MEN1KMT2ALMNARAB9AHTR7
SCHEMBL4425309 0.81 HTR1A (0.42) MEN1KMT2ALMNAHTR7HTR1A
SCHEMBL4430300 0.78 HTR1A (0.41) MEN1KMT2ALMNAHTR7HTR1A
SCHEMBL4423588 0.75 ESR1 (0.42) MEN1KMT2ALMNAHTR7HTR1A
SCHEMBL4417268 0.75 HTR7 (0.43) MEN1KMT2ALMNARAB9AHTR7
SCHEMBL4422476 0.74 HTR7 (0.60) MEN1KMT2ALMNARAB9AHTR7
SCHEMBL27520895 0.73 HTR1A (0.46) MEN1KMT2ALMNAHTR7HTR1A
SCHEMBL4429576 0.70 HTR1A (0.64) MEN1KMT2ALMNAHTR7HTR1A
SCHEMBL4419765 0.68 F10 (0.57) MEN1KMT2ALMNARAB9AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325979-A1 NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-12-31 — — US claimed
US-8492384-B2 Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-07-23 — — US disclosed
US-20090325979-A1 NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325979-A1 NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF CACNA1B, CACNA1C, ORAI1 MEN1 2657/4885KMT2A 4575/4885LMNA 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback